Lead the way to a healthier world by putting patients at the center of everything we do

We are focused on developing innovative therapies and transforming the lives of people with serious medical conditions.

Helping people with serious medical conditions lead fulfilling lives

Building on a track record of discovery, development and commercialization of important therapies, we have a robust and growing portfolio of treatments to address serious psychiatric, neurological and respiratory conditions.

Find out how we are addressing serious psychiatric conditions

We are investigating novel treatments to psychiatric disorders that will help people with these conditions live better lives.

Discover what we're doing to investigate serious neurological conditions

We are engaged in the quest for treatment paths that will improve the lives of millions impacted by neurologic conditions.

Explore our research in serious respiratory conditions

We strive to advance the science of medicine for respiratory conditions.

Featured News

May 23, 2017

Sunovion Announces Positive Results from Pivotal Study Evaluating Novel Drug Candidate Dasotraline in Adults with Binge Eating Disorder at Annual American Psychiatric Association Meeting

May 23, 2017

Sunovion Announces Utibron™ Neohaler® (indacaterol/glycopyrrolate) Inhalation Powder Data Showing Lung Function and Health-Related Quality of Life Improvement in Patients with Moderate-to-Severe Chronic Obstructive Pulmonary Disease

May 23, 2017

Sunovion Presents Phase 3 Data Showing Safety, Efficacy and Improvement in Quality of Life Outcomes in Patients with Moderate-to-Very Severe Chronic Obstructive Pulmonary Disease Treated with SUN-101/eFlow® (glycopyrrolate)

Our people share a passion to make a difference

Our Commitment

Supporting patient advocacy in our communities

We partner with leading patient advocacy organizations and participate in a wide variety of events that help to raise awareness and support educational and research programs.

Sunovion by the numbers

  • 2ndfastest-growing pharmaceutical company in the U.S.*
  • 1,600+employees worldwide
  • 20,000+employee volunteer hours in 5 years